Cargando…

A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma

Background and Objectives: The clinical prognosis and survival prediction of glioma based on gene signatures derived from heterogeneous tumor cells are unsatisfactory. This study aimed to construct an immune gene-related prognostic score model to predict the prognosis of glioma and identify patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Xuehui, Wang, Qi, Tang, Hanmin, Chen, Yuetong, Li, Xinyue, Chen, Jie, Zhang, Xinyue, Li, Yuesen, Sun, Jiahao, Han, Suxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866308/ https://www.ncbi.nlm.nih.gov/pubmed/36676646 http://dx.doi.org/10.3390/medicina59010023

Ejemplares similares

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

An Apoptosis-Related Gene Prognostic Index for Colon Cancer
por: Tang, Hanmin, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

Integrating Genome-Wide Association Studies and Gene Expression Profiles With Chemical-Genes Interaction Networks to Identify Chemicals Associated With Colorectal Cancer
por: Tan, Xinyue, et al.
Publicado: (2020)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma
por: Chen, Xinming, et al.
Publicado: (2021)

Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically
por: Gong, Liuyun, et al.
Publicado: (2023)

Tamoxifen induces fatty liver disease in breast cancer through the MAPK8/FoxO pathway
por: Gong, Liuyun, et al.
Publicado: (2020)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
por: Yin, Ting-Ting, et al.
Publicado: (2022)

Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
por: Chen, Yujia, et al.
Publicado: (2023)

Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma
por: Shi, Bo, et al.
Publicado: (2023)

Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis
por: Hou, Lin, et al.
Publicado: (2023)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma
por: Li, Longqing, et al.
Publicado: (2022)

Survival Outcomes and Prognostic Predictors in Patients With Malignant Struma Ovarii
por: Li, Sijian, et al.
Publicado: (2021)

Radiotherapy combined with anti-CEACAM1 immunotherapy to induce survival advantage in glioma
por: Li, Jinhu, et al.
Publicado: (2023)

PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma
por: Zhang, Wei, et al.
Publicado: (2023)

A Prognostic Nomogram Based on Immune Scores Predicts Postoperative Survival for Patients with Hepatocellular Carcinoma
por: Wang, Jukun, et al.
Publicado: (2020)

Identification of the prognostic and immunological roles of aquaporin 4: A potential target for survival and immunotherapy in glioma patients
por: Lan, Yu-Long, et al.
Publicado: (2022)

Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma
por: Liang, Zhongqing, et al.
Publicado: (2022)

Delivery luteolin with folacin-modified nanoparticle for glioma therapy
por: Wu, Cong, et al.
Publicado: (2019)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors
por: Chen, Xiuqiong, et al.
Publicado: (2022)

Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
por: Zeng, Yu, et al.
Publicado: (2022)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
por: Yan, Dongming, et al.
Publicado: (2022)

Cilium Expression Score Predicts Glioma Survival
por: Rajagopalan, Srinivas, et al.
Publicado: (2021)

LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy
por: Xu, Houshi, et al.
Publicado: (2021)

Serine and Metabolism Regulation: A Novel Mechanism in Antitumor Immunity and Senescence
por: Wu, Qi, et al.
Publicado: (2020)

Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon
por: Qing, Mingjie, et al.
Publicado: (2021)

Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
por: Li, Chenlu, et al.
Publicado: (2021)

A STING-related prognostic score predicts high-risk patients of colorectal cancer and provides insights into immunotherapy
por: Chen, Si-Yuan, et al.
Publicado: (2021)

The prognostic value of tumor-associated macrophages in glioma patients
por: Shen, Yang, et al.
Publicado: (2023)

Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
por: Chen, Kaijie, et al.
Publicado: (2022)

Comprehensive Analysis of Pyroptosis-Associated in Molecular Classification, Immunity and Prognostic of Glioma
por: Chen, Peng, et al.
Publicado: (2022)

An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas
por: Luo, Wei, et al.
Publicado: (2023)

Investigation into the current status of cleaning, disinfection, and sterilization of da Vinci surgical instruments—a cross-sectional survey
por: Chen, Aiqin, et al.
Publicado: (2023)

Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy
por: Zhao, Jie, et al.
Publicado: (2021)

Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication
por: Fan, Yuxiang, et al.
Publicado: (2020)

Immunotherapy in gliomas: Are we reckoning without the innate immunity?
por: Vismara, Marco Flavio Michele, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gfjfm8l1mrfqtr9u8r50bb81qj